IDXX · IDEXX Laboratories, Inc.
$504.70
-0.36% last session
End-of-day data · close of 2026-09-11
Market cap
$40B
Enterprise value
$41B
Trailing P/E
35.6
Forward P/E
30.3
Dividend yield
—
Beta
1.54
Avg volume
1M
Employees
11K
Daily Change %
-0.36%
5 Days Change
-3.78%
10 Days Change
-7.46%
30 Days Change
-12.19%
60 Days Change
-8.59%
Month to Day Change
-5.50%
Year to Day Change
-23.85%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — IDXX
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-11
Latest call per bank · past 12 months
Barclays
Overweight$710
+40.2% vs priceUBS
Neutral$670
+32.3% vs priceCitigroup
Neutral$670
+32.3% vs priceMorgan Stanley
Overweight$805
+58.9% vs priceJP Morgan
Overweight$775
+53.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Barclays | Maintains | Overweight | $800 → $710 |
| 2026-08-05 | UBS | Maintains | Neutral | $620 → $670 |
| 2026-08-05 | Citigroup | Maintains | Neutral | $650 → $670 |
| 2026-07-27 | UBS | Maintains | Neutral | $640 → $620 |
| 2026-04-28 | UBS | Maintains | Neutral | $730 → $640 |
| 2026-04-15 | Citigroup | Initiates | Neutral | $0.00 → $650 |
| 2026-03-31 | Stifel | Maintains | Buy | $775 → $675 |
| 2026-02-09 | Piper Sandler | Maintains | Neutral | $775 → $750 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 32 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 9.2% below the 50-day MA ($556.05).
- Price vs 200-day MA: Trading 16.4% below the 200-day MA ($603.46).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-4.82) — short-term momentum is fading.
- 52-week range: Price is within 10% of the 52-week low ($504.70).
IDXX Price Chart
Loading chart for IDXX…
Fundamentals
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$223B 4.7% YTD
DHR
Danaher Corporation
$141B -10.1% YTD
NTRA
Natera, Inc.
$47B 44.2% YTD
IQV
IQVIA Holdings, Inc.
$42B 14.0% YTD
A
Agilent Technologies, Inc.
$40B 7.0% YTD
WAT
Waters Corporation
$39B 6.6% YTD
ILMN
Illumina, Inc.
$30B 56.3% YTD
MTD
Mettler-Toledo International, I
$26B -7.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.